Cyclizine Hydrochloride

盐酸赛力克嗪

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameCyclizine Hydrochloride
Drug Alias Name盐酸苯甲嗪盐酸新止吐嗪Valoid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsVomitingNauseaMotion Sickness
Global Approved IndicationsVomitingNauseaMotion Sickness
Approved Indications in ChinaMotion Sickness
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Baiyunshan Pharmaceutical Co Ltd Baiyunshan Hejigong Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsVomitingNauseaMotion Sickness
Inactive IndicationsN/A

Other Information

ATC CodeR06AE03
Related LinksWikipediaDrugBankKEGG